Time filter

Source Type

Aígio, Greece

Fathi K.,Tolna County Teaching Hospital | Harangi F.,Tolna County Teaching Hospital | Kravjak A.,Tolna County Teaching Hospital | Pinter A.,Surgical Unit
Pediatric Dermatology | Year: 2014

Granuloma annulare (GA) is an uncommon benign inflammatory skin condition, most often found on the extremities of young females. The subcutaneous variant of GA involving the penis is very rare. We report a case of subcutaneous GA associated with a urethral anomaly in a 15-year-old boy that persisted for a year. Treatment options are discussed with a review of the current literature. © 2014 Wiley Periodicals, Inc.

Agbenorku P.,Kwame Nkrumah University Of Science And Technology | Agbenorku M.,Health Education Unit | Amankwa A.,Surgical Unit | Tuuli L.,Presbyterian Hospital | Saunderson P.,American Leprosy Missions
Transactions of the Royal Society of Tropical Medicine and Hygiene | Year: 2011

This study examines factors that may enhance the control and holistic treatment of Buruli ulcer in an endemic area of the Ashanti Region in Ghana. A total of 189 Buruli ulcer patients from the Bomfa sub-district were treated at the Global Evangelical Mission Hospital, Apromase - Ashanti, Ghana, from January to December 2005. Diagnosis was based on clinical findings and confirmed by any two positives of Ziehl-Neelson test for acid fast bacilli, polymerase chain reaction and histopathology. Children up to age 14 made up 43.4% of the cases; male: female ratio was 3:2. The mean duration of hospitalization was 77 days and hospital stay was significantly correlated with the time spent at home with the disease prior to admission; also, 76.7% of the cases were late ulcers. Of the 189 patients, 145 (i.e. 76.7%) were treated with antibiotics and surgery which involved excision, skin grafting with or without contracture release. A follow-up survey after the introduction of the psychosocial approach recorded fewer (85) new Buruli ulcer (BU) cases of which, the majority (78.8%, 67) were nodules and only 21.2% (18) were ulcers. Health education plays a major role in the holistic treatment of BU. This paper proposes a further study in other endemic areas on the treatment of BU with emphasis on psychosocial approach for holistic treatment. © 2011 Royal Society of Tropical Medicine and Hygiene.

Ward C.W.,Surgical Unit
MEDSURG Nursing | Year: 2012

A fast track program was implemented using best practices to prevent postoperative ileus. Patients receiving traditional care for bowel surgery were compared to patients on the fast track program. The incidence of ileus decreased 43%, and length of stay decreased 1.352 days.

Zorcolo L.,University of Cagliari | Restivo A.,University of Cagliari | Capra F.,University of Cagliari | Capra F.,Surgical Unit | And 3 more authors.
Colorectal Disease | Year: 2011

Aim The aim of the study was to define risk factors for perineal wound complications after abdominoperineal resection (APR), with particular reference to preoperative radiotherapy. Method Patients undergoing APR at our institution between 1985 and 2009 were reviewed. Wound complications were classified according to the Center for Disease Control and Prevention classification of surgical site infection (SSI). Perineal complications were identified in patients who had preoperative long-course radiotherapy (Group 1) and those who had surgery alone (Group 2). Results One hundred and fifty-seven patients met the inclusion criteria. Preoperative radiotherapy was performed in 68 (44.7%) patients (Group 1), and 89 (65.3%) patients (Group 2) underwent surgery alone. The overall rate of perineal wound complications was 14.8%. The wound infection rate was similar in each group (Group 1, 10/68, 14.7%; Group 2, 13/89, 14.9%; P=0.9). An elevated BMI (>30) was the only factor correlated with perineal morbidity on univariate analysis (P=0.01). Conclusion Preoperative radiotherapy does not influence perineal healing other than in patients with obesity. © 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Yutthakasemsunt S.,Surgical Unit | Kittiwatanagul W.,Surgical Unit | Piyavechvirat P.,Surgical Unit | Thinkamrop B.,Khon Kaen University | And 2 more authors.
BMC Emergency Medicine | Year: 2013

Background: Traumatic brain injury (TBI) is commonly accompanied by intracranial bleeding which can worsen after hospital admission. Tranexamic acid (TXA) has been shown to reduce bleeding in elective surgery and there is evidence that short courses of TXA can reduce rebleeding in spontaneous intracranial haemorrhage. We aimed to determine the effectiveness and safety of TXA in preventing progressive intracranial haemorrhage in TBI.Methods: This is a double blinded, placebo controlled randomized trial. We enrolled 238 patients older than 16 years with moderate to severe TBI (post-resuscitation Glasgow Coma Scale (GCS) 4 to 12) who had a computerized tomography (CT) brain scan within eight hours of injury and in whom there was no immediate indication for surgery. We excluded patients if they had a coagulopathy or a serum creatinine over than 2.0 milligrams%. The treatment was a single dose of 2 grams of TXA in addition to other standard treatments. The primary outcome was progressive intracranial haemorrhage (PIH) which was defined as an intracranial haemorrhage seen on the second CT scan that was not seen on the first CT scan, or an intracranial haemorrhage seen on the first scan that had expanded by 25% or more on any dimension (height, length, or width) on the second scan.Results: Progressive intracranial haemorrhage was present in 21 (18%) of 120 patients allocated to TXA and in 32 (27%) of 118 patients allocated to placebo. The difference was not statistically significant [RR = 0.65 (95% CI 0.40 to 1.05)]. There were no significant difference in the risk of death from all causes in patients allocated to TXA compared with placebo [RR = 0.69 (95% CI 0.35 to 1.39)] and the risk of unfavourable outcome on the Glasgow Outcome Scale [RR = 0.76 (95% CI 0.46 to 1.27)]. There was no evidence of increased risk of thromboembolic events in those patients allocated to TXA.Conclusions: TXA may reduce PIH in patients with TBI; however, the difference was not statistically significant in this trial. Large clinical trials are needed to confirm and to assess the effect of TXA on death or disability after TBI. © 2013 Yutthakasemsunt et al.; licensee BioMed Central Ltd.

Discover hidden collaborations